av/medicinova--big.svg

NASDAQ:MNOV

MediciNova, Inc.

  • Stock

1.47

−3.29%

0.17

USD last updated 15/08 02:20:07

Last Close

1.30

14/08 21:59

Market Cap

67.68M

Beta: 0.99

Volume Today

2.29K

Avg: 21.55K

PE Ratio

−7.21

PFCF: −6.23

OverviewFinancialsAPI

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and secondary progressive multiple sc...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    -0.15-0.1-0.052018-07-232020-02-132021-11-122023-05-112024-11-14

    Revenue (Estimate*)

    1B2B3B4B2018-07-232020-02-132021-11-122023-05-112024-11-14

    *Estimate based on analyst consensus